Immune surveillance: a balance between protumor and antitumor immunity

Swann, 2007, Immune surveillance of tumors, J Clin Invest, 117, 1137, 10.1172/JCI31405 Reiman, 2007, Tumor immunoediting and immunosculpting pathways to cancer progression, Semin Cancer Biol, 17, 275, 10.1016/j.semcancer.2007.06.009 Dunn, 2006, Interferons, immunity and cancer immunoediting, Nat Rev Immunol, 6, 836, 10.1038/nri1961 Smyth, 2006, Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity, Adv Immunol, 90, 1, 10.1016/S0065-2776(06)90001-7 Galon, 2006, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, 313, 1960, 10.1126/science.1129139 Zou, 2006, Regulatory T cells, tumour immunity and immunotherapy, Nat Rev Immunol, 6, 295, 10.1038/nri1806 Baratelli, 2005, Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells, J Immunol, 175, 1483, 10.4049/jimmunol.175.3.1483 Sharma, 2005, Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses, J Immunol, 175, 813, 10.4049/jimmunol.175.2.813 Ralainirina, 2007, Control of NK cell functions by CD4+CD25+ regulatory T cells, J Leukoc Biol, 81, 144, 10.1189/jlb.0606409 Wei, 2005, Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma, Cancer Res, 65, 5020, 10.1158/0008-5472.CAN-04-4043 Castellino, 2006, Cooperation between CD4+ and CD8+ T cells: when, where, and how, Annu Rev Immunol, 24, 519, 10.1146/annurev.immunol.23.021704.115825 Steinman, 2007, A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage, Nat Med, 13, 139, 10.1038/nm1551 Langowski, 2006, IL-23 promotes tumour incidence and growth, Nature, 442, 461, 10.1038/nature04808 Bi, 2007, Th17 cell induction and immune regulatory effects, J Cell Physiol, 211, 273, 10.1002/jcp.20973 Langowski, 2007, Swords into plowshares: IL-23 repurposes tumor immune surveillance, Trends Immunol, 28, 207, 10.1016/j.it.2007.03.006 Numasaki, 2003, Interleukin-17 promotes angiogenesis and tumor growth, Blood, 101, 2620, 10.1182/blood-2002-05-1461 Benchetrit, 2002, Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism, Blood, 99, 2114, 10.1182/blood.V99.6.2114 Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753 Nanni, 2001, Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice, J Exp Med, 194, 1195, 10.1084/jem.194.9.1195 de Visser, 2005, De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent, Cancer Cell, 7, 411, 10.1016/j.ccr.2005.04.014 Tan, 2007, Humoral immunity, inflammation and cancer, Curr Opin Immunol, 19, 209, 10.1016/j.coi.2007.01.001 Ostrand-Rosenberg S, Sinha P: Macrophages and tumor development. In Tumor-induced Immune Suppression: Mechanisms and Therapeutic Reversal. Edited by Gabrilovich D, Hurwitz A. Springer; 2008, pp. 131-155. Gordon, 2003, Alternative activation of macrophages, Nat Rev Immunol, 3, 23, 10.1038/nri978 Mills, 2000, M-1/M-2 macrophages and the Th1/Th2 paradigm, J Immunol, 164, 6166, 10.4049/jimmunol.164.12.6166 Mantovani, 2007, New vistas on macrophage differentiation and activation, Eur J Immunol, 37, 14, 10.1002/eji.200636910 Mantovani, 2006, Role of tumor-associated macrophages in tumor progression and invasion, Cancer Metastasis Rev, 25, 315, 10.1007/s10555-006-9001-7 Lin, 2006, Macrophages regulate the angiogenic switch in a mouse model of breast cancer, Cancer Res, 66, 11238, 10.1158/0008-5472.CAN-06-1278 Wyckoff, 2007, Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors, Cancer Res, 67, 2649, 10.1158/0008-5472.CAN-06-1823 Kryczek, 2006, B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma, J Exp Med, 203, 871, 10.1084/jem.20050930 Biswas, 2006, A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation), Blood, 107, 2112, 10.1182/blood-2005-01-0428 Ghassabeh, 2006, Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions, Blood, 108, 575, 10.1182/blood-2005-04-1485 Rabinovich, 2003, Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells, J Immunol, 170, 3572, 10.4049/jimmunol.170.7.3572 Ferlazzo, 2003, The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells, Eur J Immunol, 33, 306, 10.1002/immu.200310004 Barber, 2007, NK cells negatively regulate antigen presentation and tumor-specific CTLs in a syngeneic lymphoma model, J Immunol, 178, 6140, 10.4049/jimmunol.178.10.6140 Hayakawa, 2004, NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy, J Immunol, 172, 123, 10.4049/jimmunol.172.1.123 Terabe, 2005, A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance, J Exp Med, 202, 1627, 10.1084/jem.20051381 Gabrilovich, 2007, The terminology issue for myeloid-derived suppressor cells, Cancer Res, 67, 425, 10.1158/0008-5472.CAN-06-3037 Serafini, 2006, Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression, Semin Cancer Biol, 16, 53, 10.1016/j.semcancer.2005.07.005 Bunt, 2007, Tumor-associated myeloid-derived suppressor cells, 309 Sinha, 2005, Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis, Cancer Res, 65, 11743, 10.1158/0008-5472.CAN-05-0045 Yanagisawa, 2006, Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide, Cancer Res, 66, 11441, 10.1158/0008-5472.CAN-06-0944 Rodriguez, 2006, T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress, Semin Cancer Biol, 16, 66, 10.1016/j.semcancer.2005.10.001 Kusmartsev, 2006, Role of immature myeloid cells in mechanisms of immune evasion in cancer, Cancer Immunol Immunother, 55, 237, 10.1007/s00262-005-0048-z Yang, 2006, CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells, Cancer Res, 66, 6807, 10.1158/0008-5472.CAN-05-3755 Sinha, 2005, Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease, J Immunol, 174, 636, 10.4049/jimmunol.174.2.636 Bunt, 2006, Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression, J Immunol, 176, 284, 10.4049/jimmunol.176.1.284 Gallina, 2006, Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells, J Clin Invest, 116, 2777, 10.1172/JCI28828 Nagaraj, 2007, Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer, Nat Med, 13, 828, 10.1038/nm1609 Huang, 2006, Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host, Cancer Res, 66, 1123, 10.1158/0008-5472.CAN-05-1299 Sinha, 2007, Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response, J Immunol, 179, 977, 10.4049/jimmunol.179.2.977 Song, 2005, CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells, J Immunol, 175, 8200, 10.4049/jimmunol.175.12.8200 Bunt, 2007, Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression, Cancer Res, 67, 10019, 10.1158/0008-5472.CAN-07-2354 Sinha, 2007, Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells, Cancer Res, 67, 4507, 10.1158/0008-5472.CAN-06-4174 Rodriguez, 2005, Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma, J Exp Med, 202, 931, 10.1084/jem.20050715 Karin, 2005, NF-kappaB: linking inflammation and immunity to cancer development and progression, Nat Rev Immunol, 5, 749, 10.1038/nri1703 Balkwill, 2005, Smoldering and polarized inflammation in the initiation and promotion of malignant disease, Cancer Cell, 7, 211, 10.1016/j.ccr.2005.02.013 de Visser, 2006, Paradoxical roles of the immune system during cancer development, Nat Rev Cancer, 6, 24, 10.1038/nrc1782